D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CBAY holding history
CymaBay Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CBAY overviewAll 13F holders of CBAYFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −636,897−100.0% | Sold out | Holders |
| Q4 2023 | 636,897 | $15.0M | <0.1% | −161,112−20.2% | Reduced | Holders |
| Q3 2023 | 798,009 | $11.9M | <0.1% | +105,608+15.3% | Added | Holders |
| Q2 2023 | 692,401 | $7.58M | <0.1% | +143,357+26.1% | Added | Holders |
| Q1 2023 | 549,044 | $4.79M | <0.1% | +280,849+104.7% | Added | Holders |
| Q4 2022 | 268,195 | $1.68M | <0.1% | +43,582+19.4% | Added | Holders |
| Q3 2022 | 224,613 | $786.0K | <0.1% | −40,728−15.3% | Reduced | Holders |
| Q2 2022 | 265,341 | $782.0K | <0.1% | −44,941−14.5% | Reduced | Holders |
| Q1 2022 | 310,282 | $965.0K | <0.1% | +63,494+25.7% | Added | Holders |
| Q4 2021 | 246,788 | $835.0K | <0.1% | −101,910−29.2% | Reduced | Holders |
| Q3 2021 | 348,698 | $1.27M | <0.1% | −248,029−41.6% | Reduced | Holders |
| Q2 2021 | 596,727 | $2.60M | <0.1% | −359,794−37.6% | Reduced | Holders |
| Q1 2021 | 956,521 | $4.34M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.